<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40623210</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>10</Issue><PubDate><Year>2025</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Days at Home Up to 30 Days After Robotic Versus Laparoscopic Colorectal Surgery.</ArticleTitle><Pagination><StartPage>1207</StartPage><EndPage>1214</EndPage><MedlinePgn>1207-1214</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003861</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">"Days at home up to 30 days" is a novel patient-centered outcome metric that measures the number of days patients spend at home 30 days after surgery. It encompasses inpatient stay from index admission, interhospital transfers and step-downs, and readmissions across different hospitals.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Comparison of days at home up to 30 days and established outcome metrics after robotic versus 3-dimensional laparoscopic colorectal surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective cohort study of consecutive patients.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Townsville University Hospital and Mater Private Hospital, Townsville, Queensland, Australia.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Adult patients undergoing robotic and 3-dimensional laparoscopic colorectal surgery.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Days at home up to 30 days, 30-day readmission rate, index admission length, and 30-day postoperative complication rates.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 82 patients, 32 (39%) underwent robotic and 50 (61%) underwent 3-dimensional laparoscopic colorectal surgery. Robotic ultralow and low anterior resection, as well as abdominoperineal resection, resulted in significantly more days at home (23 vs 15 days at home, p = 0.05) and a shorter length of index admission (7 vs 15 days in hospital, p = 0.0003). However, there was no significant difference in major postoperative complications and 30-day readmission rate. No significant differences were found between robotic and 3-dimensional laparoscopic right hemicolectomy or high anterior resection.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Unrandomized study. Patient selection for robotic and 3-dimensional laparoscopic surgery was at the surgeons' discretion.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients undergoing robotic ultralow and low anterior resection, as well as abdominoperineal resection, spent more days at home 30 days after index surgery due to a reduction in the length of the index hospital admission. Days at home up to 30 days may enhance the informed consent and complement traditional end points in future clinical trials. See Abstract Video .</AbstractText><AbstractText Label="DAS EN CASA HASTA DAS DESPUS DE LA CIRUGA COLORRECTAL ROBTICA FRENTE A LA LAPAROSCPICA" NlmCategory="UNASSIGNED">ANTECEDENTES:&#xab;D&#xed;as en el hogar hasta 30 d&#xed;as&#xbb; es una nueva m&#xe9;trica de resultados centrada en el paciente que mide el n&#xfa;mero de d&#xed;as que los pacientes pasan en su hogar 30 d&#xed;as despu&#xe9;s de la cirug&#xed;a. Abarca la estancia hospitalaria desde el ingreso inicial, los traslados entre hospitales y los traslados a unidades de cuidados intermedios, as&#xed; como los reingresos en diferentes hospitales.OBJETIVO:Comparaci&#xf3;n de los d&#xed;as en casa hasta 30 d&#xed;as y las m&#xe9;tricas de resultados establecidas tras la cirug&#xed;a rob&#xf3;tica frente a la cirug&#xed;a laparosc&#xf3;pica tridimensional.DISE&#xd1;O:Estudio prospectivo de cohortes de pacientes consecutivos.ENTORNO:Hospital Universitario de Townsville y Hospital Privado Mater, Townsville, Queensland, Australia.PACIENTES:Pacientes adultos sometidos a cirug&#xed;a colorrectal rob&#xf3;tica y laparosc&#xf3;pica tridimensional.PRINCIPALES MEDIDAS DE RESULTADO:D&#xed;as en el domicilio hasta 30 d&#xed;as, tasa de reingresos a los 30 d&#xed;as, duraci&#xf3;n de la admisi&#xf3;n inicial y tasas de complicaciones postoperatorias a los 30 d&#xed;as.RESULTADOS:De los 82 pacientes, 32 (39 %) se sometieron a cirug&#xed;a rob&#xf3;tica y 50 (61 %) a cirug&#xed;a colorrectal laparosc&#xf3;pica tridimensional. La resecci&#xf3;n anterior rob&#xf3;tica ultrabaja y baja, as&#xed; como la resecci&#xf3;n abdominoperineal, dieron lugar a un n&#xfa;mero significativamente mayor de d&#xed;as en el domicilio (23 frente a 15 d&#xed;as en el domicilio, p = 0,05) y a una menor duraci&#xf3;n de la hospitalizaci&#xf3;n inicial (7 frente a 15 d&#xed;as en el hospital, p = 0,0003). Sin embargo, no se observaron diferencias significativas en las complicaciones postoperatorias graves ni en la tasa de reingresos a los 30 d&#xed;as. No se encontraron diferencias significativas entre la hemicolectom&#xed;a derecha rob&#xf3;tica y laparosc&#xf3;pica tridimensional, as&#xed; como la resecci&#xf3;n anterior alta.LIMITACIONES:Estudio no aleatorizado. La selecci&#xf3;n de los pacientes para la cirug&#xed;a rob&#xf3;tica y laparosc&#xf3;pica tridimensional se realiz&#xf3; a criterio de los cirujanos.CONCLUSI&#xd3;N:Los pacientes sometidos a resecci&#xf3;n anterior rob&#xf3;tica ultrabaja y baja, as&#xed; como a resecci&#xf3;n abdominoperineal, pasaron m&#xe1;s d&#xed;as en casa 30 d&#xed;as despu&#xe9;s de la cirug&#xed;a &#xed;ndice debido a la reducci&#xf3;n de la duraci&#xf3;n de la hospitalizaci&#xf3;n &#xed;ndice. Los d&#xed;as en casa hasta 30 d&#xed;as pueden mejorar el consentimiento informado y complementar los criterios de valoraci&#xf3;n tradicionales en futuros ensayos cl&#xed;nicos. (AI-generated translation ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wickramasinghe</LastName><ForeName>Shehan S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0003-4735-2129</Identifier><AffiliationInfo><Affiliation>Division of Colorectal Surgery, Department of Surgery, Townsville University Hospital, Townsville, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Kerenaftali</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Returned and Services League of Australia, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pornkul</LastName><ForeName>Panuwat</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Colorectal Surgery, Department of Surgery, Townsville University Hospital, Townsville, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mushaya</LastName><ForeName>Chrispen D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Division of Colorectal Surgery, Department of Surgery, Townsville University Hospital, Townsville, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>David W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakata</LastName><ForeName>Shinichiro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Colorectal Surgery, Department of Surgery, Townsville University Hospital, Townsville, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="Y">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011793" MajorTopicYN="N" Type="Geographic">Queensland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="Y">Colectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colorectal surgery</Keyword><Keyword MajorTopicYN="N">Days at home up to 30 days</Keyword><Keyword MajorTopicYN="N">Days to home</Keyword><Keyword MajorTopicYN="N">Robotic surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>16</Day><Hour>13</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>7</Day><Hour>18</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>7</Day><Hour>15</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40623210</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003861</ArticleId><ArticleId IdType="pii">00003453-990000000-00993</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Erozkan K, Gorgun E. Robotic colorectal surgery and future directions. Am J Surg. 2024;230:91&#x2013;98.</Citation></Reference><Reference><Citation>Yeung TM, Larkins KM, Satish KW, Alexander GH. The rise of robotic colorectal surgery: better for patients and better for surgeons. J Robot Surg. 2024;18:69.</Citation></Reference><Reference><Citation>Sakata S, Grove PM, Stevenson AR. Effect of 3-dimensional vision on surgeons using the da Vinci robot for laparoscopy: more than meets the eye. JAMA Surg. 2016;151:793&#x2013;794.</Citation></Reference><Reference><Citation>Jayne D, Pigazzi A, Marshall H, et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA. 2017;318:1569&#x2013;1580.</Citation></Reference><Reference><Citation>Feng Q, Yuan W, Li T, et al.; REAL Study Group. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol. 2022;7:991&#x2013;1004.</Citation></Reference><Reference><Citation>Angehrn FVS, Schneider R, Wilhelm A, et al. Robotic versus laparoscopic low anterior resection following neoadjuvant chemoradiation therapy for stage II-III locally advanced rectal cancer: a single-centre cohort study. J Robot Surg. 2022;16:1133&#x2013;1141.</Citation></Reference><Reference><Citation>Hettiarachchi TS, Askari A, Rudge E, et al. Comparison of robotic vs laparoscopic left-sided colorectal cancer resections. J Robot Surg. 2023;17:205&#x2013;213.</Citation></Reference><Reference><Citation>Lim S, Nagai Y, Nozawa H, et al. Surgical outcomes of robotic, laparoscopic, and open low anterior resection after preoperative chemoradiotherapy for patients with advanced lower rectal cancer. Surg Today. 2023;53:109&#x2013;115.</Citation></Reference><Reference><Citation>Bell M, Eriksson LI, Svensson T, et al. Days at home after surgery: an integrated and efficient outcome measure for clinical trials and quality assurance. EClin Med. 2019;11:18&#x2013;26.</Citation></Reference><Reference><Citation>Myles PS, Shulman MA, Heritier S, et al. Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia. BMJ Open. 2017;7:e015828.</Citation></Reference><Reference><Citation>Jerath A, Austin PC, Wijeysundera DN. Days alive and out of hospital: validation of a patient-centered outcome for perioperative medicine. Anesthesiology. 2019;131:84&#x2013;93.</Citation></Reference><Reference><Citation>Flynn J, Larach JT, Kong JCH, et al. Operative and oncological outcomes after robotic rectal resection compared with laparoscopy: a systematic review and meta-analysis. ANZ J Surg. 2023;93:510&#x2013;521.</Citation></Reference><Reference><Citation>Khan MH, Tahir A, Hussain A, Monis A, Zahid S, Fatima M. Outcomes of robotic versus laparoscopic-assisted surgery in patients with rectal cancer: a systematic review and meta-analysis. Langenbecks Arch Surg. 2024;409:269.</Citation></Reference><Reference><Citation>Feng Q, Tang W, Zhang Z, et al. Robotic versus laparoscopic abdominoperineal resections for low rectal cancer: a single-center randomized controlled trial. J Surg Oncol. 2022;126:1481&#x2013;1493.</Citation></Reference><Reference><Citation>Sakata S, Watson MO, Grove PM, Stevenson AR. The conflicting evidence of three-dimensional displays in laparoscopy: a review of systems old and new. Ann Surg. 2016;263:234&#x2013;239.</Citation></Reference><Reference><Citation>Sakata S, Grove PM, Hill A, Watson MO, Stevenson ARL. Impact of simulated three-dimensional perception on precision of depth judgements, technical performance and perceived workload in laparoscopy. Br J Surg. 2017;104:1097&#x2013;1106.</Citation></Reference><Reference><Citation>Bastawrous AL, Shih I-F, Li Y, Cleary RK. Minimally invasive sigmoidectomy for diverticular disease decreases inpatient opioid use: results of a propensity score-matched study. Am J Surg. 2020;220:421&#x2013;427.</Citation></Reference><Reference><Citation>Bastawrous AL, Brockhaus KK, Chang MI, et al. A national database propensity score-matched comparison of minimally invasive and open colectomy for long-term opioid use. Surg Endosc. 2022;36:701&#x2013;710.</Citation></Reference><Reference><Citation>Berger Y, Khajoueinejad N, Imtiaz S, et al. Robotic colorectal resections are associated with less postoperative pain, decreased opioid use, and earlier return to work as compared to the laparoscopic approach. J Robot Surg. 2024;18:336.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40192141</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Short- and Long-term Outcomes After Continent Ileostomy: An Often Forgotten Option for Patients After Proctocolectomy.</ArticleTitle><Pagination><StartPage>887</StartPage><EndPage>898</EndPage><MedlinePgn>887-898</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003720</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Continent ileostomy is an alternative for reconstruction after proctocolectomy when IPAA is not feasible. Due to technical difficulties and patient preference, few centers still perform these operations. Recent literature focuses on ileostomies that are as old as 40 years, and there is a dearth of information on newly constructed continent ileostomies.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate outcomes and patient satisfaction in a group of new continent ileostomy patients.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective case series.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Urban academic center.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">All patients undergoing continent ileostomy creation, revision, or excision between 2013 and 2022 were included.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Continent ileostomy.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Short-term outcomes included length of stay, complications, reoperation, and readmission within 30 days. Long-term outcomes included pouch revision, retention, quality of life, and functional outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty patients underwent 95 procedures. Thirty-eight patients (63% women, mean age 45 years) had their ileostomies created at our center. The mean hospitalization was 8.4 days. Readmission rate was 29%, reoperation rate was 5%, and mortality rate was 0%. Major complications (leak or pelvic abscess) occurred in 11% and minor complications (ileus, transfusions) in 58%. Pouch revision was needed in 34% of patients (major 24%, minor 11%) and pouch retention in 87% after 37 months. Forty-two patients with prior ileostomies (75% women, mean age 55 years) underwent 57 revisions/excisions. The mean hospitalization was 5.1 days; readmission rate was 7%. Major complications occurred in 6% and minor complications in 14% ot patients. There was 1 reoperation and no deaths. Repeat pouch revision rate was 21% (major 9%, minor 12%) and pouch retention rate was 88% after 42 months. Functional outcomes and quality of life on follow-up were excellent, with 92% of the creation group reporting improvement in function and quality of life and 93% of the revision group reporting improvement.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Retrospective design, case series.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A continent ileostomy program is feasible in the contemporary era, with good short- and long-term outcomes and excellent patient satisfaction. See Video Abstract .</AbstractText><AbstractText Label="RESULTADOS A CORTO Y LARGO PLAZO TRAS UNA ILEOSTOMA CONTINENTE UNA OPCIN A MENUDO OLVIDADA PARA LOS PACIENTES TRAS UNA PROCTOCOLECTOMA" NlmCategory="UNASSIGNED">ANTECEDENTES:La ileostom&#xed;a continente es una alternativa para la reconstrucci&#xf3;n tras la proctocolectom&#xed;a cuando la anastomosis ileoanal no es factible. Debido a la dificultad t&#xe9;cnica o a la preferencia del paciente, pocos centros a&#xfa;n realizan estas operaciones. La literatura reciente se centra en ileostom&#xed;as con una antig&#xfc;edad de hasta 40 a&#xf1;os, con escasez de informaci&#xf3;n sobre ileostom&#xed;as continentes de nueva construcci&#xf3;n.OBJETIVO:Evaluar los resultados y la satisfacci&#xf3;n del paciente en un grupo de pacientes con ileostom&#xed;a continente de nueva construcci&#xf3;n.DISE&#xd1;O:Serie de casos retrospectiva.ESCENARIO:Centro acad&#xe9;mico urbano.PACIENTES:Todos los pacientes sometidos a creaci&#xf3;n, revisi&#xf3;n o escisi&#xf3;n de ileostom&#xed;a continente entre 2013 y 2022.INTERVENCI&#xd3;N:Ileostom&#xed;a continente.PRINCIPALES MEDIDAS DE RESULTADOS:Resultados a corto plazo (estancia hospitalaria, complicaciones, reintervenci&#xf3;n y reingreso en 30 d&#xed;as); resultados a largo plazo (revisi&#xf3;n del reservorio, retenci&#xf3;n, calidad de vida y resultado funcional).RESULTADOS:80 pacientes se sometieron a 95 procedimientos. A 38 pacientes (63% mujeres, edad media de 45 a&#xf1;os) se les realiz&#xf3; una ileostom&#xed;a en nuestro centro. La hospitalizaci&#xf3;n media fue de 8,4 d&#xed;as. El reingreso fue del 29%, la reintervenci&#xf3;n del 5% y la mortalidad del 0%. Se produjeron complicaciones mayores (fuga o absceso p&#xe9;lvico) en el 11% y complicaciones menores (&#xed;leo, transfusiones) en el 58%. La revisi&#xf3;n de la bolsa fue del 34% (mayor 24%, menor 11%) y la retenci&#xf3;n de la bolsa fue del 87% despu&#xe9;s de 37 meses. 42 pacientes con ileostom&#xed;as previas (75% mujeres, edad media de 55 a&#xf1;os) se sometieron a 57 revisiones/escisiones. La hospitalizaci&#xf3;n media fue de 5,1 d&#xed;as; el reingreso fue del 7%. Se produjeron complicaciones mayores en el 6% y complicaciones menores en el 14%. Hubo una reintervenci&#xf3;n y ninguna muerte. La re-revisi&#xf3;n de la bolsa fue del 21% (mayor 9%, menor 12%) y la retenci&#xf3;n de la bolsa del 88% despu&#xe9;s de 42 meses. Los resultados funcionales y la calidad de vida durante el seguimiento fueron excelentes: el 92% del grupo de creaci&#xf3;n report&#xf3; una mejora en la funci&#xf3;n y la calidad de vida, y el 93% del grupo de revisi&#xf3;n report&#xf3; una mejora.LIMITACIONES:Dise&#xf1;o retrospectivo, serie de casos.CONCLUSIONES Y RELEVANCIA:Un programa de ileostom&#xed;a continente es viable en la era actual, con buenos resultados a corto y largo plazo y una excelente satisfacci&#xf3;n del paciente. (Traducci&#xf3;n-Dr Yolanda Colorado ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kiran</LastName><ForeName>Ravi P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Global Center for Integrated Colorectal Surgery and IBD Interventional Endoscopy, Columbia University Irving Medical Center/NewYork Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Beatrix H</ForeName><Initials>BH</Initials></Author><Author ValidYN="Y"><LastName>Herman</LastName><ForeName>Koby</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Bo</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Church</LastName><ForeName>James M</ForeName><Initials>JM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007081" MajorTopicYN="Y">Ileostomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016737" MajorTopicYN="Y">Proctocolectomy, Restorative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="N">Patient Satisfaction</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039021" MajorTopicYN="N">Colonic Pouches</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Continent ileostomy</Keyword><Keyword MajorTopicYN="N">IBD</Keyword><Keyword MajorTopicYN="N">Pouch</Keyword><Keyword MajorTopicYN="N">Proctocolectomy</Keyword><Keyword MajorTopicYN="N">Ulcerative colitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>12</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>7</Day><Hour>13</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>7</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40192141</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003720</ArticleId><ArticleId IdType="pii">00003453-202507000-00015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kock NG. Intra-abdominal &#x201c;reservoir&#x201d; in patients with permanent ileostomy. Preliminary observations on a procedure resulting in fecal &#x201c;continence&#x201d; in five ileostomy patients. Arch Surg. 1969;99:223&#x2013;231.</Citation></Reference><Reference><Citation>Nessar G, Fazio VW, Tekkis P, et al. Long-term outcome and quality of life after continent ileostomy. Dis Colon Rectum. 2006;49:336&#x2013;344.</Citation></Reference><Reference><Citation>Fazio VW, Church JM. Complications and function of the continent ileostomy at the Cleveland Clinic. World J Surg. 1988;12:148&#x2013;154.</Citation></Reference><Reference><Citation>Sj&#xf6;dahl R, Lemon E, Nystr&#xf6;m PO, Olaison G. Complications, surgical revision and quality of life with conventional and continent ileostomy. Acta Chir Scand. 1990;156:403&#x2013;407.</Citation></Reference><Reference><Citation>Litle VR, Barbour S, Schrock TR, Welton ML. The continent ileostomy: long-term durability and patient satisfaction. J Gastrointest Surg. 1999;3:625&#x2013;632.</Citation></Reference><Reference><Citation>Castillo E, Thomassie LM, Whitlow CB, Margolin DA, Malcolm J, Beck DE. Continent ileostomy: current experience. Dis Colon Rectum. 2005;48:1263&#x2013;1268.</Citation></Reference><Reference><Citation>Wasmuth HH, Svins&#xe5;s M, Tran&#xf8; G, et al. Surgical load and long-term outcome for patients with Kock continent ileostomy. Colorectal Dis. 2007;9:713&#x2013;717.</Citation></Reference><Reference><Citation>Lian L, Fazio VW, Remzi FH, Shen B, Dietz D, Kiran RP. Outcomes for patients undergoing continent ileostomy after a failed ileal pouch-anal anastomosis. Dis Colon Rectum. 2009;52:1409&#x2013;4414.</Citation></Reference><Reference><Citation>Parc Y, Klouche M, Bennis M, Lef&#xe8;vre JH, Shields C, Tiret E. The continent ileostomy: an alternative to end ileostomy? Short and long-term results of a single institution series. Dig Liver Dis. 2011;43:779&#x2013;783.</Citation></Reference><Reference><Citation>Aytac E, Dietz DW, Ashburn J, Remzi FH. Long-term outcomes after continent ileostomy creation in patients with Crohn&#x2019;s disease. Dis Colon Rectum. 2017;60:508&#x2013;513.</Citation></Reference><Reference><Citation>Ecker NKJ, M&#xf6;slein G, Ecker KW. Continent ileostomy: short- and long-term outcomes of a forgotten procedure. BJS Open. 2021;5:zrab095.</Citation></Reference><Reference><Citation>Risto A, Hallb&#xf6;&#xf6;k O, Andersson P, Sj&#xf6;dahl R, Myrelid P. Long-term follow-up, patient satisfaction, and quality of life for patients with Kock&#x2019;s continent ileostomy. Dis Colon Rectum. 2021;64:420&#x2013;428.</Citation></Reference><Reference><Citation>Ecker KW, T&#xf6;nsmann M, Ecker NKJ, M&#xf6;slein G. Salvage surgery for continent ileostomies (CI) after a first successful revision: more long-term blame on the reservoir than the nipple valve. Int J Colorectal Dis. 2022;37:553&#x2013;561.</Citation></Reference><Reference><Citation>Risto A, Andersson RE, Landerholm K, Bengtsson J, Block M, Myrelid P. Reoperations and long-term survival of Kock&#x2019;s continent ileostomy in inflammatory bowel disease patients: a population based national cohort study from Sweden. Dis Colon Rectum. 2022;66:1492&#x2013;1499.</Citation></Reference><Reference><Citation>Ware J Jr, Kosinski M, Keller SDA. 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220&#x2013;233.</Citation></Reference><Reference><Citation>Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1171&#x2013;1178.</Citation></Reference><Reference><Citation>Gash K, Kiran RP. The formation of a Kock pouch (continent ileostomy)&#x2014;a video vignette. Colorectal Dis. 2019;21:974&#x2013;975.</Citation></Reference><Reference><Citation>Ware JE, Kosinski M, Keller SD. How to Score the SF-12 Physical &amp; Mental Health Summary Scales. 2nd ed. Boston: The Health Institute, New England Medical Center; 1995.</Citation></Reference><Reference><Citation>Ng KS, Gonsalves SJ, Sagar PM. Ileal-anal pouches: a review of its history, indications, and complications. World J Gastroenterol. 2019;25:4320&#x2013;4342.</Citation></Reference><Reference><Citation>Cranley B. The Kock reservoir ileostomy: a review of its development, problems and role in modern surgical practice. Br J Surg. 1983;70:94&#x2013;99.</Citation></Reference><Reference><Citation>Goligher JC, Lintott D. Experience with 26 reservoir ileostomies. Br J Surg. 1975;62:893&#x2013;900.</Citation></Reference><Reference><Citation>Gelernt IM, Bauer JJ, Kreel I. The reservoir ileostomy: early experience with 54 patients. Ann Surg. 1977;185:179&#x2013;184.</Citation></Reference><Reference><Citation>Halvorsen JF, Heimann P, Hoel R, Nygaard K. The continent reservoir ileostomy: review of a collective series of thirty-six patients from three surgical departments. Surgery. 1978;83:252&#x2013;258.</Citation></Reference><Reference><Citation>Goldman SL, Rombeau JL. The continent ileostomy: a collective review. Dis Colon Rectum. 1978;21:594&#x2013;599.</Citation></Reference><Reference><Citation>Kock NG, Myrvold HE, Nilsson LO, Philipson BM. Continent ileostomy. An account of 314 patients. Acta Chir Scand. 1981;147:67&#x2013;72.</Citation></Reference><Reference><Citation>Beahrs OH. Present status of the continent ileostomy: ileal reservoir with ileostomy rather than ileostomy alone. Dis Colon Rectum. 1976;19:192&#x2013;194.</Citation></Reference><Reference><Citation>Kock NG, Brevinge H, Philipson BM, Ojerskog B. Continent ileostomy. The present technique and long term results. Ann Chir Gynaecol. 1986;75:63&#x2013;70.</Citation></Reference><Reference><Citation>Nessar G, Remzi FH, Wu JS. Evolving technique for continent ileostomy: valveless pouch design. Tech Coloproctol. 2004;8:49&#x2013;52.</Citation></Reference><Reference><Citation>Fazio VW, Tjandra JJ. Technique for nipple valve fixation to prevent valve slippage in continent ileostomy. Dis Colon Rectum. 1992;35:1177&#x2013;1179.</Citation></Reference><Reference><Citation>Bokey L, Fazio VW. The mesenteric sling technique: new method of constructing an intestinal nipple valve for the continent ileostomy. Cleve Clin Q. 1978;45:231&#x2013;236.</Citation></Reference><Reference><Citation>Dozois RR, Kelly KA, Beart RW Jr, Beahrs OH. Improved results with continent ileostomy. Ann Surg. 1980;192:319&#x2013;324.</Citation></Reference><Reference><Citation>Abelson JS, Michelassi F, Mao J, Sedrakyan A, Yeo H. Higher surgical morbidity for ulcerative colitis patients in the era of biologics. Ann Surg. 2018;268:311&#x2013;317.</Citation></Reference><Reference><Citation>Wu XR, Ke HX, Kiran RP, Shen B, Lan P. Continent ileostomy as an alternative to end ileostomy. Gastroenterol Res Pract. 2020;2020:9740980.</Citation></Reference><Reference><Citation>Kock NG, Darle N, Kewenter J, Myrvold H, Philipson B. The quality of life after proctocolectomy and ileostomy: a study of patients with conventional ileostomies converted to continent ileostomies. Dis Colon Rectum. 1974;17:287&#x2013;292.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">39808079</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-Wait.</ArticleTitle><Pagination><StartPage>300</StartPage><EndPage>307</EndPage><MedlinePgn>300-307</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003538</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The watch-and-wait strategy provides an opportunity to pursue nonoperative management in rectal cancer patients with clinical complete response after neoadjuvant therapy. The management of those with near-complete response remains controversial.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We assessed the oncologic outcomes of patients managed by watch-and-wait versus total mesorectal excision according to clinical response to neoadjuvant therapy.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Comprehensive cancer center in New York.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients with rectal adenocarcinoma diagnosed between January 2006 and December 2020.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">A watch-and-wait strategy of active surveillance was offered to patients if they achieved clinical complete response. Salvage surgery was used for watch-and-wait patients with local regrowth. Patients with an incomplete response underwent total mesorectal excision.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Local regrowth rate, organ preservation rate, disease-free survival, and overall survival.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients with rectal adenocarcinoma (n = 1230) were divided into 3 response cohorts-incomplete (n = 646), near-complete (n = 189), and complete (n = 395). Eighty-one patients (43%) in the near-complete group and 351 patients (89%) in the complete group entered watch-and-wait. Three-year local regrowth rates were 40% and 24% in the near-complete and complete response cohorts, respectively. The 5-year organ preservation rate was 53% in near-complete responders and 73% in complete responders. Five-year disease-free survival increased with greater clinical response to neoadjuvant therapy, with intermediate outcomes noted for patients with a near-complete (73%) compared to complete (82%) or incomplete (68%) response. Overall survival at 5 years was similar between the 3 cohorts (complete 90%, near-complete 86%, and incomplete 85%).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Retrospective nature.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Greater clinical response to neoadjuvant therapy is associated with improved oncologic outcomes. Near-complete responders may avoid surgery and still achieve high organ preservation rates yet experience greater local regrowth rates than clinical complete response patients. Ongoing prospective trials integrating watch-and-wait after complete response as determined by uniform criteria will bolster the work to help treating physicians better select patients who qualify for active surveillance. See Video Abstract .</AbstractText><AbstractText Label="CORRELACIN ENTRE EL GRADO DE RESPUESTA CLNICA A LA TERAPIA NEOADYUVANTE CONTRA EL CNCER DEL RECTO Y LOS RESULTADOS ONCOLGICOS EN LA ERA DE OBSERVAR Y ESPERAR" NlmCategory="UNASSIGNED">ANTECEDENTES:La estrategia de observar y esperar brinda la oportunidad de buscar un tratamiento no quir&#xfa;rgico en pacientes con c&#xe1;ncer del recto con respuesta cl&#xed;nica completa despu&#xe9;s de la terapia neoadyuvante. El tratamiento de aquellos con respuesta casi completa sigue siendo controversial.OBJETIVO:Evaluamos los resultados oncol&#xf3;gicos de los pacientes tratados con observar y esperar versus escisi&#xf3;n mesorrectal total seg&#xfa;n la respuesta cl&#xed;nica a la terapia neoadyuvante.DISE&#xd1;O:Estudio de cohorte retrospectivo.CONFIGURACI&#xd3;N:Centro oncol&#xf3;gico integral en Nueva York.PACIENTES:Pacientes con adenocarcinoma rectal diagnosticado entre enero de 2006 y diciembre de 2020.INTERVENCIONES:Se ofreci&#xf3; una estrategia de observar y esperar de vigilancia activa a los pacientes si lograban una respuesta cl&#xed;nica completa. Se utiliz&#xf3; cirug&#xed;a de rescate para pacientes en observar y esperar con recrecimiento local. Los pacientes con una respuesta incompleta se sometieron a escisi&#xf3;n mesorrectal total.PRINCIPALES MEDIDAS DE RESULTADO:Tasa de recrecimiento local, tasa de preservaci&#xf3;n de &#xf3;rganos, supervivencia libre de enfermedad y supervivencia general.RESULTADOS:Los pacientes con adenocarcinoma rectal (n = 1230) se dividieron en 3 cohortes de respuesta: incompleta (n = 646), casi completa (n = 189) y completa (n = 395). Ochenta y un (43%) pacientes en el grupo casi completo y 351 (89%) pacientes en el grupo completo ingresaron en observar y esperar. Las tasas de recrecimiento local a tres a&#xf1;os fueron del 40% y 24% en las cohortes de respuesta casi completa y completa, respectivamente. La tasa de preservaci&#xf3;n de &#xf3;rganos a 5 a&#xf1;os fue del 53% en los respondedores casi completos y del 73% en los respondedores completos. La supervivencia libre de enfermedad a cinco a&#xf1;os aument&#xf3; con una mayor respuesta cl&#xed;nica a la terapia neoadyuvante con resultados intermedios observados para pacientes con una respuesta casi completa (73%) en comparaci&#xf3;n con la completa (82%) o incompleta (68%). La supervivencia global a los 5 a&#xf1;os fue similar entre las tres cohortes (completa 90%, casi completa 86% e incompleta 85%).LIMITACIONES:Naturaleza retrospectiva.CONCLUSI&#xd3;N:Una mayor respuesta cl&#xed;nica a la terapia neoadyuvante se asocia con mejores resultados oncol&#xf3;gicos. Los pacientes con respuesta casi completa pueden evitar la cirug&#xed;a y aun as&#xed; lograr altas tasas de preservaci&#xf3;n de &#xf3;rganos, pero experimentar mayores tasas de recrecimiento local que los pacientes con respuesta cl&#xed;nica completa. Los ensayos prospectivos en curso que integran observar y esperar despu&#xe9;s de la respuesta completa seg&#xfa;n lo determinado por criterios uniformes reforzar&#xe1;n el trabajo para ayudar a los m&#xe9;dicos tratantes a seleccionar mejor a los pacientes que califican para la vigilancia activa. (Traducci&#xf3;n-Dr. Aurian Garcia Gonzalez ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rosen</LastName><ForeName>Roni Y</ForeName><Initials>RY</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bercz</LastName><ForeName>Aron P</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0002-4259-2644</Identifier><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omer</LastName><ForeName>Dana M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0002-2259-2540</Identifier><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verheij</LastName><ForeName>Floris S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malekzadeh</LastName><ForeName>Parisa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Danielle L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quezada-Diaz</LastName><ForeName>Felipe F</ForeName><Initials>FF</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Iris H</ForeName><Initials>IH</Initials><Identifier Source="ORCID">0000-0001-9006-9105</Identifier><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Widmar</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1145-8370</Identifier><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karagkounis</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0759-8108</Identifier><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roth O'Brien</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajj</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crane</LastName><ForeName>Christopher H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Neil H</ForeName><Initials>NH</Initials><Identifier Source="ORCID">0000-0002-3047-2303</Identifier><AffiliationInfo><Affiliation>Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shcherba</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganesh</LastName><ForeName>Karuna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yaeger</LastName><ForeName>Rona</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7233-5454</Identifier><AffiliationInfo><Affiliation>Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappou</LastName><ForeName>Emmanouil</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8735-1852</Identifier><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romesser</LastName><ForeName>Paul B</ForeName><Initials>PB</Initials><Identifier Source="ORCID">0000-0001-8268-2903</Identifier><AffiliationInfo><Affiliation>Department Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nash</LastName><ForeName>Garrett M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saltz</LastName><ForeName>Leonard B</ForeName><Initials>LB</Initials><Identifier Source="ORCID">0000-0001-8353-4670</Identifier><AffiliationInfo><Affiliation>Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cercek</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5054-8192</Identifier><AffiliationInfo><Affiliation>Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiser</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;nen</LastName><ForeName>Mithat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paty</LastName><ForeName>Philip B</ForeName><Initials>PB</Initials><Identifier Source="ORCID">0000-0002-7045-2112</Identifier><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Aguilar</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>J Joshua</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 CA255574</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 CA248289</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057832" MajorTopicYN="Y">Watchful Waiting</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="Y">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020360" MajorTopicYN="Y">Neoadjuvant Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000095384" MajorTopicYN="N">Pathologic Complete Response</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078542" MajorTopicYN="N">Proctectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="Y">Adenocarcinoma</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016879" MajorTopicYN="N">Salvage Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="Y">Neoplasm Recurrence, Local</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060787" MajorTopicYN="N">Neoplasm Grading</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="ANTECEDENTES:">La estrategia de observaci&#xf3;n y espera brinda la oportunidad de buscar un tratamiento no quir&#xfa;rgico en pacientes con c&#xe1;ncer de recto con respuesta cl&#xed;nica completa despu&#xe9;s de la terapia neoadyuvante. El tratamiento de aquellos con respuesta casi completa sigue siendo controvertido.</AbstractText><AbstractText Label="OBJETIVO:">Evaluamos los resultados oncol&#xf3;gicos de los pacientes tratados con observaci&#xf3;n y espera versus escisi&#xf3;n mesorrectal total seg&#xfa;n la respuesta cl&#xed;nica a la terapia neoadyuvante.</AbstractText><AbstractText Label="DISE&#xd1;O:">Estudio de cohorte retrospectivo.</AbstractText><AbstractText Label="CONFIGURACI&#xd3;N:">Centro oncol&#xf3;gico integral en Nueva York.</AbstractText><AbstractText Label="PACIENTES:">Pacientes con adenocarcinoma rectal diagnosticado entre enero de 2006 y diciembre de 2020.</AbstractText><AbstractText Label="INTERVENCIONES:">Se ofreci&#xf3; una estrategia de observaci&#xf3;n y espera de vigilancia activa a los pacientes si lograban una respuesta cl&#xed;nica completa. Se utiliz&#xf3; cirug&#xed;a de rescate para pacientes con observaci&#xf3;n y espera con recrecimiento local. Los pacientes con una respuesta incompleta se sometieron a escisi&#xf3;n mesorrectal total.</AbstractText><AbstractText Label="PRINCIPALES MEDIDAS DE RESULTADO:">Tasa de recrecimiento local, tasa de preservaci&#xf3;n de &#xf3;rganos, supervivencia libre de enfermedad y supervivencia general. Resultados: Los pacientes con adenocarcinoma rectal (n = 1230) se dividieron en 3 cohortes de respuesta: incompleta (n = 646), casi completa (n = 189) y completa (n = 395). Ochenta y un (43%) pacientes en el grupo casi completo y 351 (89%) pacientes en el grupo completo ingresaron en observaci&#xf3;n y espera. Las tasas de recrecimiento local a tres a&#xf1;os fueron del 40% y 24% en las cohortes de respuesta casi completa y completa, respectivamente. La tasa de preservaci&#xf3;n de &#xf3;rganos a 5 a&#xf1;os fue del 53% en los respondedores casi completos y del 73% en los respondedores completos. La supervivencia libre de enfermedad a cinco a&#xf1;os aument&#xf3; con una mayor respuesta cl&#xed;nica a la terapia neoadyuvante con resultados intermedios observados para pacientes con una respuesta casi completa (73%) en comparaci&#xf3;n con la completa (82%) o incompleta (68%). La supervivencia global a los 5 a&#xf1;os fue similar entre las tres cohortes (completa 90%, casi completa 86% e incompleta 85%).</AbstractText><AbstractText Label="LIMITACIONES:">Naturaleza retrospectiva.</AbstractText><AbstractText Label="CONCLUSI&#xd3;N:">Una mayor respuesta cl&#xed;nica a la terapia neoadyuvante se asocia con mejores resultados oncol&#xf3;gicos. Los pacientes con respuesta casi completa pueden evitar la cirug&#xed;a y aun as&#xed; lograr altas tasas de preservaci&#xf3;n de &#xf3;rganos, pero experimentar mayores tasas de recrecimiento local que los pacientes con respuesta cl&#xed;nica completa. Los ensayos prospectivos en curso que integran la observaci&#xf3;n y espera despu&#xe9;s de la respuesta completa seg&#xfa;n lo determinado por criterios uniformes reforzar&#xe1;n el trabajo para ayudar a los m&#xe9;dicos tratantes a seleccionar mejor a los pacientes que califican para la vigilancia activa.</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2026</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>14</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>14</Day><Hour>10</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39808079</ArticleId><ArticleId IdType="mid">NIHMS2076100</ArticleId><ArticleId IdType="pmc">PMC12203740</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003538</ArticleId><ArticleId IdType="pii">00003453-990000000-00809</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240:711&#x2013;717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1356472</ArticleId><ArticleId IdType="pubmed">15383798</ArticleId></ArticleIdList></Reference><Reference><Citation>Cercek A, Roxburgh CSD, Strombom P, et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol. 2018;4:e180071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5885165</ArticleId><ArticleId IdType="pubmed">29566109</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Aguilar J, Chow OS, Smith DD, et al. ; Timing of Rectal Cancer Response to Chemoradiation Consortium. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol. 2015;16:957&#x2013;966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4670237</ArticleId><ArticleId IdType="pubmed">26187751</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Aguilar J, Patil S, Gollub MJ, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;40:2546&#x2013;2556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9362876</ArticleId><ArticleId IdType="pubmed">35483010</ArticleId></ArticleIdList></Reference><Reference><Citation>Verheij FS, Omer DM, Williams H, et al. Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA Trial. J Clin Oncol. 2024;42:500&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11578087</ArticleId><ArticleId IdType="pubmed">37883738</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith JJ, Strombom P, Chow OS, et al. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol. 2019;5:e185896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6459120</ArticleId><ArticleId IdType="pubmed">30629084</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Valk MJM, Hilling DE, Bastiaannet E, et al. ; IWWD Consortium. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch &amp; Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391:2537&#x2013;2545.</Citation><ArticleIdList><ArticleId IdType="pubmed">29976470</ArticleId></ArticleIdList></Reference><Reference><Citation>Fokas E, Appelt A, Glynne-Jones R, et al. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nat Rev Clin Oncol. 2021;18:805&#x2013;816.</Citation><ArticleIdList><ArticleId IdType="pubmed">34349247</ArticleId></ArticleIdList></Reference><Reference><Citation>Custers PA, Geubels BM, Beets GL, et al. Defining near-complete response following (chemo)radiotherapy for rectal cancer: systematic review. Br J Surg. 2022;110:43&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">36349555</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith JJ, Chow OS, Gollub MJ, et al. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC Cancer. 2015;15:767. Published 2015 Oct 23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4619249</ArticleId><ArticleId IdType="pubmed">26497495</ArticleId></ArticleIdList></Reference><Reference><Citation>Habr-Gama A, S&#xe3;o Juli&#xe3;o GP, Fernandez LM, et al. achieving a complete clinical response after neoadjuvant chemoradiation that does not require surgical resection: it may take longer than you think! Dis Colon Rectum. 2019;62:802&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">31188180</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;del C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23:8688&#x2013;8696.</Citation><ArticleIdList><ArticleId IdType="pubmed">16246976</ArticleId></ArticleIdList></Reference><Reference><Citation>Fokas E, Liersch T, Fietkau R, et al. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. J Clin Oncol. 2014;32:1554&#x2013;1562.</Citation><ArticleIdList><ArticleId IdType="pubmed">24752056</ArticleId></ArticleIdList></Reference><Reference><Citation>Fokas E, Str&#xf6;bel P, Fietkau R, et al. Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. J Natl Cancer Inst. 2017;109(12): 10.1093/jnci/djx095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djx095</ArticleId><ArticleId IdType="pubmed">29206996</ArticleId></ArticleIdList></Reference><Reference><Citation>Temmink SJD, Peeters KCMJ, Bahadoer RR, et al. ; International Watch &amp; Wait Database (IWWD) Consortium. Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch &amp; Wait Database (IWWD). Br J Surg. 2023;110:676&#x2013;684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10364523</ArticleId><ArticleId IdType="pubmed">36972213</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson HM, Omer DM, Lin S, et al. Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial [published correction appears in JAMA Netw Open. 2024 Feb 5;7(2):e242456]. JAMA Netw Open. 2024;7(1):e2350903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10777257</ArticleId><ArticleId IdType="pubmed">38194231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hupkens BJP, Maas M, Martens MH, et al. Organ preservation in rectal cancer after chemoradiation: should we extend the observation period in patients with a clinical near-complete response? Ann Surg Oncol. 2018;25:197&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">29134378</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloothaak DA, Geijsen DE, van Leersum NJ, et al. ; Dutch Surgical Colorectal Audit. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg. 2013;100:933&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">23536485</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez LM, S&#xe3;o Juli&#xe3;o GP, Renehan AG, et al. ; International Watch &amp; Wait Database (IWWD) Consortium. The risk of distant metastases in patients with clinical complete response managed by watch and wait after neoadjuvant therapy for rectal cancer: the influence of local regrowth in the international watch and wait database. Dis Colon Rectum. 2023;66:41&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">36515514</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe3;o Juli&#xe3;o GP, Karagkounis G, Fernandez LM, et al. Conditional survival in patients with rectal cancer and complete clinical response managed by watch and wait after chemoradiation: recurrence risk over time. Ann Surg. 2020;272:138&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">30946085</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen R, Bercz A, Williams H, et al. Correlation between grade of clinical response to neoadjuvant therapy for rectal cancer and oncologic outcomes in the era of watch-and-wait [ASCRS abstract SS06]. Dis Colon Rectum. 2024;67:e436&#x2013;e437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12203740</ArticleId><ArticleId IdType="pubmed">39808079</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39325029</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Long Rectal Cuff and Remnant Mesorectum Are Major Preventable Causes of Ileal Pouch Failure.</ArticleTitle><Pagination><StartPage>69</StartPage><EndPage>76</EndPage><MedlinePgn>69-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003530</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long rectal cuff (&gt;2&#x2009;cm) and remnant mesorectum are known causes of pouch dysfunction because of obstructive defecation as well as pelvic sepsis after prolonged obstruction.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to report the rates and management of patients who underwent redo IPAA because of pouch failure associated with a retained mesorectum and long rectal cuff.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This is a retrospective study.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">The investigation is based on data from a quaternary IBD center.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients undergoing redo IPAA surgery with a long rectal cuff and/or remnant mesorectum between September 2016 and September 2023 were included in the study.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The main outcomes were functioning pouch rate and functional results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 245 patients who underwent redo IPAA surgery, 98 patients (40%) had long rectal cuff and/or remnant mesorectum. Redo IPAA in this patient group was successful (92%) at a median follow-up of 28 (18-52) months.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The retrospective nature of the study and inclusion of a single specialized center.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Long rectal cuff and remnant mesorectum are major causes of pouch failure, which can be successfully managed with redo IPAA surgery. Nearly half of pouch failure patients who had successful redo IPAA surgery initially received unnecessary biologic therapy before coming to our center. See Video Abstract .</AbstractText><AbstractText Label="MUON RECTAL LARGO Y MESORRECTO REMANENTE SON LAS PRINCIPALES CAUSAS PREVENIBLES DE DISFUNCIN DE LA BOLSA ILEAL" NlmCategory="UNASSIGNED">ANTECEDENTES:El mu&#xf1;on rectal largo (&gt;2 cm) y el mesorrecto remanente son causas conocidas de disfunci&#xf3;n de la bolsa debido a defecaci&#xf3;n obstructiva, as&#xed; como de sepsis p&#xe9;lvica tras obstrucci&#xf3;n prolongada.OBJETIVO:El objetivo de este estudio es informar las tasas y el tratamiento de los pacientes que se sometieron a una nueva anastomosis anal con bolsa ileal debido al fracaso de la bolsa asociado a mesorrecto remanente y el mu&#xf1;on rectal largo.DISE&#xd1;O:Se trata de un estudio retrospectivo.LUGAR:La investigaci&#xf3;n se basa en un centro cuaternario de enfermedad inflamatoria intestinal.PACIENTES:Se incluyeron en el estudio los pacientes sometidos a una nueva cirug&#xed;a de anastomosis anal con bolsa ileal y que ten&#xed;an mu&#xf1;on rectal largo y/o mesorrecto remanente entre septiembre de 2016 y septiembre de 2023.PRINCIPALES MEDIDAS DE VALORACI&#xd3;N:Los principales resultados fueron la tasa de funcionamiento de la bolsa y los resultados funcionales.RESULTADOS:De los 245 pacientes que se sometieron a una nueva cirug&#xed;a de anastomosis anal con bolsa ileal, 98 (40%) pacientes ten&#xed;an un mu&#xf1;on rectal largo y/o mesorrecto remanente. La repetici&#xf3;n de la anastomosis anal con bolsa ileal en este grupo de pacientes fue exitosa (92%) en una mediana de seguimiento de 28 (18-52) meses.LIMITACIONES:La naturaleza retrospectiva del estudio y la experiencia de un solo centro especializado.CONCLUSIONES:El mu&#xf1;on rectal largo y el mesorrecto remanente son las principales causas de fracaso de la bolsa, que pueden tratarse con &#xe9;xito mediante una nueva cirug&#xed;a de anastomosis anal con bolsa ileal. Casi la mitad de los pacientes con fracaso de la bolsa que se sometieron con &#xe9;xito a una nueva cirug&#xed;a de anastomosis anal con bolsa ileal recibieron inicialmente un tratamiento biol&#xf3;gico innecesario antes de acudir a nuestro centro. (Traducci&#xf3;n-Ingrid Melo ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gulmez</LastName><ForeName>Mehmet</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Inflammatory Bowel Disease Center, NYU Langone Health, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hinduja</LastName><ForeName>Pranav</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Esen</LastName><ForeName>Eren</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Grieco</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Erkan</LastName><ForeName>Arman</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>da Luz Moreira</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kirat</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Remzi</LastName><ForeName>Feza H</ForeName><Initials>FH</Initials><Identifier Source="ORCID">0000-0001-6227-8620</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016737" MajorTopicYN="Y">Proctocolectomy, Restorative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039021" MajorTopicYN="Y">Colonic Pouches</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="Y">Reoperation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012007" MajorTopicYN="Y">Rectum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003093" MajorTopicYN="N">Colitis, Ulcerative</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>16</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39325029</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003530</ArticleId><ArticleId IdType="pii">00003453-990000000-00757</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995;222:120&#x2013;127.</Citation></Reference><Reference><Citation>Fazio VW, Kiran RP, Remzi FH, et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg. 2013;257:679&#x2013;685.</Citation></Reference><Reference><Citation>Sagap I, Remzi FH, Hammel JP, Fazio VW. Factors associated with failure in managing pelvic sepsis after ileal pouch-anal anastomosis (IPAA)&#x2014;a multivariate analysis. Surgery. 2006;140:691&#x2013;703.</Citation></Reference><Reference><Citation>Tulchinsky H, Hawley PR, Nicholls J. Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg. 2003;238:229&#x2013;234.</Citation></Reference><Reference><Citation>Remzi FH, Fazio VW, Kirat HT, Wu JS, Lavery IC, Kiran RP. Repeat pouch surgery by the abdominal approach safely salvages failed ileal pelvic pouch. Dis Colon Rectum. 2009;52:198&#x2013;204.</Citation></Reference><Reference><Citation>Remzi FH, Aytac E, Ashburn J, et al. Transabdominal redo ileal pouch surgery for failed restorative proctocolectomy: lessons learned over 500 patients. Ann Surg. 2015;262:675&#x2013;682.</Citation></Reference><Reference><Citation>Fazio VW, O&#x2019;Riordain MG, Lavery IC, et al. Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg. 1999;230:575&#x2013;584.</Citation></Reference><Reference><Citation>Huang C, Remzi FH, Dane B, et al. Reporting templates for MRI and water-soluble contrast enema in patients with ileal pouch-anal anastomosis: experience from a large referral center. AJR Am J Roentgenol. 2021;217:347&#x2013;358.</Citation></Reference><Reference><Citation>Schwartzberg DM, Esen E, Remzi FH. Thoughtful ileostomy creation in patients undergoing redo IPAA. Dis Colon Rectum. 2020;63:117&#x2013;120.</Citation></Reference><Reference><Citation>Aydinli HH, Peirce C, Aytac E, Remzi F. The usefulness of the H-pouch configuration in salvage surgery for failed ileal pouches. Colorectal Dis. 2017;19:e312&#x2013;e315.</Citation></Reference><Reference><Citation>Gulmez M, Hinduja P, Esen E, et al. Pouch failure is often caused by remnant mesorectum or long rectal cuff [ASCRS abstract QS206]. Dis Colon Rectum. 2024;67:e476&#x2013;e477.</Citation></Reference><Reference><Citation>Bartels SA, Gardenbroek TJ, Aarts M, et al. Short-term morbidity and quality of life from a randomized clinical trial of close rectal dissection and total mesorectal excision in ileal pouch-anal anastomosis. Br J Surg. 2015;102:281&#x2013;287.</Citation></Reference><Reference><Citation>Rink AD, Radinski I, Vestweber KH. Does mesorectal preservation protect the ileoanal anastomosis after restorative proctocolectomy? J Gastrointest Surg. 2009;13:120&#x2013;128.</Citation></Reference><Reference><Citation>Grieco MJ, Remzi FH. Surgical management of ulcerative colitis. Gastroenterol Clin North Am. 2020;49:753&#x2013;768.</Citation></Reference><Reference><Citation>Aydinli HH, Esen E, Aytac E, et al. Transabdominal pouch salvage for failed minimally invasive versus open IPAA: a case-matched study. Dis Colon Rectum. 2020;63:1102&#x2013;1107.</Citation></Reference><Reference><Citation>Spinelli A, Foppa C, Maroli A, et al. Transanal transection and single-stapling techniques are associated with shorter rectal cuff and lower urgency rate after pouch surgery compared with the double-stapled approach. Surgery. 2023;174:808&#x2013;812.</Citation></Reference><Reference><Citation>Maspero M, Liska D, Kessler H, et al. Redo IPAA for long rectal cuff syndrome after ileoanal pouch for inflammatory bowel disease. Tech Coloproctol. 2024;28:38.</Citation></Reference><Reference><Citation>Akova U, Wong D, Gulmez M, et al. Pouch abandonment is extremely rare even in the reoperative setting: a high-volume referral center experience. Surgery. 2024;176:676&#x2013;679.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39260442</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Impact of the Diverting Stoma on Renal Function.</ArticleTitle><Pagination><StartPage>1576</StartPage><EndPage>1583</EndPage><MedlinePgn>1576-1583</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003517</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although loop ileostomy as a diverting stoma has been considered to affect renal dysfunction, few reports have compared loop colostomy with loop ileostomy regarding renal function. This is an important issue in the current setting of increased opportunities to perform surgery on patients with poor renal function.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to reveal the effect of ileostomy on renal dysfunction compared to colostomy after sphincter-preserving rectal surgery.</AbstractText><AbstractText Label="DESIGN">This study was a retrospective analysis. We compared preoperative and postoperative values of blood urea nitrogen, serum creatinine, and estimated glomerular filtration rate.</AbstractText><AbstractText Label="SETTINGS">The study was conducted at a single academic institution in Osaka, Japan.</AbstractText><AbstractText Label="PATIENTS">From October 2013 to November 2021, 135 consecutive patients who underwent rectal surgery with diverting stoma were included.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Differences in pre- and postoperative renal function values by stoma creation site in patients with preoperative chronic kidney disease. Risk factors for patients with newly developed kidney disease after stoma creation.</AbstractText><AbstractText Label="RESULTS">In the preoperative chronic kidney disease (+) patients, the differences between the pre- and postoperative values of blood urea nitrogen ( p = 0.047) and serum creatinine ( p = 0.028) were higher than in the preoperative chronic kidney disease (-) patients. In the preoperative chronic kidney disease (+) patients, ileostomy was significantly associated with an elevation of the serum creatinine value ( p = 0.025) and a decrease in estimated glomerular filtration rate value ( p = 0.041) from preoperative values compared with that of colostomy. In multivariate analysis, ileostomy (OR; 7.443, p = 0.011) and hypertension (4.226, p = 0.008) were independent risk factors of newly developed kidney disease postoperatively.</AbstractText><AbstractText Label="LIMITATIONS">Limitations to our study include its retrospective nature and bias because of the stoma site being determined by each surgeon.</AbstractText><AbstractText Label="CONCLUSIONS">We should take care to choose diverting stoma especially in patients with a risk of kidney dysfunction. See Video Abstract .</AbstractText><AbstractText Label="IMPACTO DE UNA OSTOMA DE DERIVACIN SOBRE LA FUNCIN RENAL">ANTECEDENTES:Apesar de haberse considerado que la ileostom&#xed;a en asa de derivaci&#xf3;n afecta la funci&#xf3;n renal, pocos informes han comparado la colostom&#xed;a de asa con la ileostom&#xed;a de asa y ambas con respecto a la funci&#xf3;n renal. Esta es un problema importante en el contexto actual de mayores oportunidades para realizar cirug&#xed;a en pacientes con funci&#xf3;n renal deficitaria.OBJETIVO:El presente estudio tiene como objetivo revelar el efecto de la ileostom&#xed;a en asa sobre la funci&#xf3;n renal comparada con la colostom&#xed;a en asa despu&#xe9;s de una cirug&#xed;a rectal con preservaci&#xf3;n de esf&#xed;nteres.DISE&#xd1;O:Estudio de an&#xe1;lisis retrospectivo. Comparamos los valores de nitr&#xf3;geno ureico en sangre en el pre-operatorio y el post-operatorio, la creatinina s&#xe9;rica y la tasa estimada de filtraci&#xf3;n glomerular.AJUSTES:Estudio lleavado a cabo en una sola instituci&#xf3;n acad&#xe9;mica en Osaka, Jap&#xf3;n.PACIENTES:Desde octubre de 2013 hasta noviembre de 2021, se incluyeron consecutivamente 135 pacientes sometidos a cirug&#xed;a rectal con ostom&#xed;a de derivaci&#xf3;n.PRINCIPALES MEDIDAS DE RESULTADO:Las diferencias en los valores de la funci&#xf3;n renal pre y post-operatorias seg&#xfa;n el sitio de creaci&#xf3;n de las ostom&#xed;a en pacientes con enfermedad renal cr&#xf3;nica pre-operatoria. Tambi&#xe9;n los factores de riesgo para pacientes con enfermedad renal reciente despu&#xe9;s de la creaci&#xf3;n de una ostom&#xed;a.RESULTADOS:En los pacientes con enfermedad renal cr&#xf3;nica pre-operatoria (+), las diferencias entre los valores pre y post en el nitr&#xf3;geno ureico en sangre (p = 0,047) y los valores de creatinina s&#xe9;rica (p = 0,028) fueron mayores que en los pacientes con enfermedad renal cr&#xf3;nica pre-operatoria (+) y los pacientes con enfermedad renal (-).En los pacientes con enfermedad renal cr&#xf3;nica (+) pre-operatoria, la ileostom&#xed;a se asoci&#xf3; significativamente con una elevaci&#xf3;n del valor de creatinina s&#xe9;rica (p = 0,025) y una disminuci&#xf3;n en el valor estimado de la tasa de filtraci&#xf3;n glomerular (p = 0,041) con respecto al valor pre-operatorio en comparaci&#xf3;n con el de la colostom&#xed;a.En el an&#xe1;lisis multivariado, la ileostom&#xed;a (Odds Ratio; 7,443, p = 0,011) y la hipertensi&#xf3;n (4,226, P = 0,008) fueron factores de riesgo independientes de nueva enfermedad renal en el post-operatorio.LIMITACIONES:Las limitaciones de nuestro estudio incluyen su naturaleza retrospectiva y el sesgo debido a que cada cirujano determina el sitio de la confecci&#xf3;n ostomial.CONCLUSI&#xd3;N:Se debe tener cuidado en elegir el tipo de ostom&#xed;a derivativa especialmente en pacientes con riesgo de disfunci&#xf3;n renal. (Traducci&#xf3;n-Dr. Xavier Delgadillo ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yagyu</LastName><ForeName>Takuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Kansai Medical University Hospital, Hirakata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamada</LastName><ForeName>Madoka</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8629-7436</Identifier><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Kansai Medical University Hospital, Hirakata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hatta</LastName><ForeName>Masahiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Kansai Medical University Hospital, Hirakata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Toshinori</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Kansai Medical University Hospital, Hirakata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumi</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Kansai Medical University Hospital, Hirakata, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inada</LastName><ForeName>Ryo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Kansai Medical University Hospital, Hirakata, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery, Kochi Health Sciences Centre, Kochi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Tomoko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Kansai Medical University Hospital, Hirakata, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery, Coloproctology Center Takano Hospital, Kumamoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oishi</LastName><ForeName>Masaharu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Kansai Medical University Hospital, Hirakata, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oishi Clinic, Minoh, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007081" MajorTopicYN="Y">Ileostomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003125" MajorTopicYN="Y">Colostomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001806" MajorTopicYN="N">Blood Urea Nitrogen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054047" MajorTopicYN="N">Surgical Stomas</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diverting stoma</Keyword><Keyword MajorTopicYN="N">Loop colostomy</Keyword><Keyword MajorTopicYN="N">Loop ileostomy</Keyword><Keyword MajorTopicYN="N">Rectal surgery</Keyword><Keyword MajorTopicYN="N">Renal function</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>6</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39260442</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003517</ArticleId><ArticleId IdType="pii">00003453-990000000-00746</ArticleId></ArticleIdList><ReferenceList><Title/><Reference><Citation>Shiomi A, Ito M, Saito N, et al. The indications for a diverting stoma in low anterior resection for rectal cancer: a prospective multicentre study of 222 patients from Japanese cancer centers. Colorectal Dis. 2011;13:1384&#x2013;1389.</Citation></Reference><Reference><Citation>Shiomi A, Ito M, Maeda K, et al. Effects of a diverting stoma on symptomatic anastomotic leakage after low anterior resection for rectal cancer: a propensity score matching analysis of 1,014 consecutive patients. J Am Coll Surg. 2015;220:186&#x2013;194.</Citation></Reference><Reference><Citation>Marusch F, Koch A, Schmidt U, et al. Value of a protective stoma in low anterior resections for rectal cancer. Dis Colon Rectum. 2002;45:1164&#x2013;1171.</Citation></Reference><Reference><Citation>R&#xe4;s&#xe4;nen M, Renkonen-Sinisalo L, Carpelan-Holmstr&#xf6;m M, Lepist&#xf6; A. Low anterior resection combined with a covering stoma in the treatment of rectal cancer reduces the risk of permanent anastomotic failure. Int J Colorectal Dis. 2015;30:1323&#x2013;1328.</Citation></Reference><Reference><Citation>Wu SW, Ma CC, Yang Y. Role of protective stoma in low anterior resection for rectal cancer: a meta-analysis. World J Gastroenterol. 2014;20:18031&#x2013;18037.</Citation></Reference><Reference><Citation>Ge Z, Zhao X, Liu Z, et al. Complications of preventive loop ileostomy versus colostomy: a meta-analysis, trial sequential analysis, and systematic review. BMC Surg. 2023;23:235.</Citation></Reference><Reference><Citation>Gavriilidis P, Azoulay D, Taflampas P. Loop transverse colostomy versus loop ileostomy for defunctioning of colorectal anastomosis: a systematic review, updated conventional meta-analysis, and cumulative meta-analysis. Surg Today. 2019;49:108&#x2013;117.</Citation></Reference><Reference><Citation>Davis BR, Valente MA, Goldberg JE, Lightner AL, Feingold DL, Paquette IM; Prepared on behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons clinical practice guidelines for ostomy surgery. Dis Colon Rectum. 2022;65:1173&#x2013;1190.</Citation></Reference><Reference><Citation>Lee GC, Kanters AE, Gunter RL, et al. Operative management of anastomotic leak after sigmoid colectomy for left-sided diverticular disease: ileostomy creation may be as safe as colostomy creation. Colorectal Dis. 2023;25:1257&#x2013;1266.</Citation></Reference><Reference><Citation>Alqahtani M, Garfinkle R, Zhao K, et al. Can we better predict readmission for dehydration following creation of a diverting loop ileostomy: development and validation of a prediction model and web-based risk calculator. Surg Endosc. 2020;34:3118&#x2013;3125.</Citation></Reference><Reference><Citation>Chen SY, Stem M, Cerullo M, et al. Predicting the risk of readmission from dehydration after ileostomy formation: the dehydration readmission after ileostomy prediction score. Dis Colon Rectum. 2018;61:1410&#x2013;1417.</Citation></Reference><Reference><Citation>Justiniano CF, Temple LK, Swanger AA, et al. Readmissions with dehydration after ileostomy creation: rethinking risk factors. Dis Colon Rectum. 2018;61:1297&#x2013;1305.</Citation></Reference><Reference><Citation>Kim NE, Hall JF. Risk factors for readmission after ileostomy creation: an NSQIP database study. J Gastrointest Surg. 2021;25:1010&#x2013;1018.</Citation></Reference><Reference><Citation>Hoshino N, Hida K, Fukui Y, Takahashi Y, Nakayama T, Obama K. Relationship between diverting stoma and adjuvant chemotherapy in patients with rectal cancer: a nationwide study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Int J Clin Oncol. 2022;27:545&#x2013;552.</Citation></Reference><Reference><Citation>Jafari MD, Jafari F, Halabi WJ, et al. Colorectal cancer resections in the aging US population: a trend toward decreasing rates and improved outcomes. JAMA Surg. 2014;149:557&#x2013;564.</Citation></Reference><Reference><Citation>Baldea AJ. Effect of aging on renal function plus monitoring and support. Surg Clin North Am. 2015;95:71&#x2013;83.</Citation></Reference><Reference><Citation>Hommos MS, Glassock RJ, Rule AD. Structural and functional changes in human kidneys with healthy aging. J Am Soc Nephrol. 2017;28:2838&#x2013;2844.</Citation></Reference><Reference><Citation>Fielding A, Woods R, Moosvi SR, et al. Renal impairment after ileostomy formation: a frequent event with long-term consequences. Colorectal Dis. 2020;22:269&#x2013;278.</Citation></Reference><Reference><Citation>Ishani A, Xue JL, Himmelfarb J, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20:223&#x2013;228.</Citation></Reference><Reference><Citation>van Kuijk JP, Flu WJ, Chonchol M, et al. Temporary perioperative decline of renal function is an independent predictor for chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:1198&#x2013;1204.</Citation></Reference><Reference><Citation>Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296&#x2013;1305.</Citation></Reference><Reference><Citation>Borucki JP, Woods R, Fielding A, et al. Postoperative decline in renal function after rectal resection and all-cause mortality: a retrospective cohort study. Colorectal Dis. 2023;25:2225&#x2013;2232.</Citation></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604&#x2013;612.</Citation></Reference><Reference><Citation>Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825&#x2013;830.</Citation></Reference><Reference><Citation>Ebi KL, Capon A, Berry P, et al. Hot weather and heat extremes: health risks. Lancet. 2021;398:698&#x2013;708.</Citation></Reference><Reference><Citation>Masoud A, McKenna ZJ, Li Z, et al. Strategies to mitigate acute kidney injury risk during physical work in hot environments. Am J Physiol Renal Physiol. 2024;326:F499&#x2013;F510.doi:10.1152/ajprenal.00350.2023. Epub ahead of print. PMID: 38299216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00350.2023</ArticleId></ArticleIdList></Reference><Reference><Citation>Gessler B, Haglind E, Angenete E. A temporary loop ileostomy affects renal function. Int J Colorectal Dis. 2014;29:1131&#x2013;1135.</Citation></Reference><Reference><Citation>Yaegashi M, Otsuka K, Kimura T, et al. Early renal dysfunction after temporary ileostomy construction. Surg Today. 2020;50:703&#x2013;710.</Citation></Reference><Reference><Citation>Smith SA, Ronksley PE, Tan Z, et al. New ileostomy formation and subsequent community-onset acute and chronic kidney disease: a population-based cohort study. Ann Surg. 2021;274:352&#x2013;358.</Citation></Reference><Reference><Citation>Yang K, Zhao J, Chu L, et al. Temporary impairment of renal function in patients with rectal cancer treated with diverting ileostomy. J Gastrointest Oncol. 2021;12:620&#x2013;629.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39239958</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Radially Emitting Diode Laser Closure of Transsphincteric Fistula-in-Ano.</ArticleTitle><Pagination><StartPage>1555</StartPage><EndPage>1563</EndPage><MedlinePgn>1555-1563</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003501</ELocationID><Abstract><AbstractText Label="BACKGROUND">There has been a shift in the treatment of fistula-in-ano toward a focus on the preservation of continence while simultaneously eradicating the disease. The utilization of radially emitting diode laser catheters to ablate fistula tracks has been described since 2011, with heterogenous studies publishing success rates ranging from 20% to 89%.</AbstractText><AbstractText Label="OBJECTIVE">Present the authors' experience managing solitary transsphincteric fistulas of cryptoglandular origin with a radially emitting diode laser.</AbstractText><AbstractText Label="DESIGN">Prospective nonrandomized single center trial with 12-month follow-up.</AbstractText><AbstractText Label="SETTINGS">Quaternary referral academic health care center.</AbstractText><AbstractText Label="PATIENTS">Forty-six adults with transsphincteric fistula-in-ano.</AbstractText><AbstractText Label="INTERVENTIONS">All patients underwent radially emitting diode laser closure of fistula-in-ano.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Clinical healing and fistula recurrence.</AbstractText><AbstractText Label="RESULTS">Forty-six patients with a median age of 48 years (range, 26-85) underwent diode laser closure. Most were men (n = 28; 60%). Twenty-four patients (52%) had previous fistula repairs with a median of 1.5 (range, 1-7) repairs per patient. All were followed for 12 months. Successful closure after 1 laser treatment occurred in 43% of patients. Thirteen of 26 failure cases (50%) were able to undergo a delayed fistulotomy secondary to an anatomic change with the fistula becoming more superficial, moving out of the internal sphincter muscle after laser ablation, all of which healed. No patients experienced new or worsening (preexisting) fecal incontinence. Two patients (8%) continued treatment for abscesses/fistula branching. One patient (3%) experienced migration of the fistula from the base of the left labia to the introitus of the vagina and 1 experienced recurrence and worsening of their disease process with subsequent involvement of the coccyx (previous deep postanal space abscess).</AbstractText><AbstractText Label="LIMITATIONS">Limitations to our study include its nonrandomized prospective nature, single center and surgeon experience, and small patient sample size.</AbstractText><AbstractText Label="CONCLUSIONS">Radially emitting diode laser closure is a continence-preserving option to consider when treating transsphincteric fistula-in-ano. When the procedure fails, it does not fail poorly (open wounds, retracted flaps, incontinence, etc) and can be repeated. Complications can include abscess formation and fistula migration to adjacent anatomic locations (vagina). Even if unsuccessful, after treatment, the fistula can anatomically migrate distally, becoming more superficial and thus providing the opportunity to proceed with a delayed fistulotomy. See Video Abstract .</AbstractText><AbstractText Label="CIERRE DE FSTULA ANAL TRANSESFINTRICA CON LSER DE DIODO DE EMISIN RADIAL">ANTECEDENTES:Ha habido un cambio en el tratamiento de la f&#xed;stula anal hacia un enfoque en la preservaci&#xf3;n de la continencia y al mismo tiempo en la erradicaci&#xf3;n de la enfermedad. La utilizaci&#xf3;n de cat&#xe9;teres l&#xe1;ser de diodo de emisi&#xf3;n radial para extirpar los trayectos de las f&#xed;stulas se describe desde el 2011 y estudios heterog&#xe9;neos publican tasas de &#xe9;xito que oscilan entre el 20 y el 89%.OBJETIVO:Presentar nuestra experiencia en el manejo de f&#xed;stulas transesfinterianas solitarias de origen criptoglandular con l&#xe1;ser de diodo de emisi&#xf3;n radial.DISE&#xd1;O:Ensayo prospectivo, no aleatorizado, unic&#xe9;ntrico, con seguimiento de 12 meses.LUGARES:Centro de salud acad&#xe9;mico de referencia Cuaternario.PACIENTES:Cuarenta y seis adultos con f&#xed;stula anal transesfint&#xe9;rica.INTERVENCIONES:Todos se sometieron a cierre de f&#xed;stula anal con l&#xe1;ser de diodo de emisi&#xf3;n radial.MEDIDAS PRINCIPALES DEL RESULTADO:Curaci&#xf3;n cl&#xed;nica y recurrencia de la f&#xed;stula.RESULTADOS:Cuarenta y seis pacientes con una mediana de edad de 48 a&#xf1;os (rango, 26-85) se sometieron a cierre con l&#xe1;ser de diodo. La mayor&#xed;a eran hombres (n=28/60%). Veinticuatro (52%) hab&#xed;an tenido reparaciones previas de f&#xed;stulas con una mediana de 1,5 (rango, 1-7) reparaciones por paciente. Todos fueron seguidos durante 12 meses. El cierre exitoso despu&#xe9;s de un tratamiento con l&#xe1;ser se produjo en el 43%. Trece de 26 fracasos (50%) pudieron someterse a una fistulotom&#xed;a tard&#xed;a debido a un cambio anat&#xf3;mico en el que la f&#xed;stula se volvi&#xf3; m&#xe1;s superficial y sali&#xf3; del m&#xfa;sculo del esf&#xed;nter interno despu&#xe9;s de la ablaci&#xf3;n con l&#xe1;ser, y todas sanaron. Ning&#xfa;n paciente experiment&#xf3; incontinencia fecal nueva o que empeor&#xf3; (preexistente). Dos (8%) continuaron tratamiento por abscesos/ramificaci&#xf3;n de f&#xed;stulas. Una (3%) experiment&#xf3; migraci&#xf3;n de la f&#xed;stula desde la base de los labios izquierdos hasta el introito de la vagina y 1 experiment&#xf3; recurrencia y empeoramiento de su proceso patol&#xf3;gico con posterior afectaci&#xf3;n del c&#xf3;ccix (absceso previo en el espacio postanal profundo).LIMITACIONES:Las limitaciones de nuestro estudio incluyen su naturaleza prospectiva no aleatoria, la experiencia de un solo centro y del cirujano y el tama&#xf1;o peque&#xf1;o de la muestra de pacientes.CONCLUSIONES:El cierre con l&#xe1;ser de diodo de emisi&#xf3;n radial es una opci&#xf3;n para preservar la continencia a considerar cuando se trata la f&#xed;stula en el ano transesfint&#xe9;rica. Cuando el procedimiento fracasa, no fracasa mal (heridas abiertas, colgajos retra&#xed;dos, incontinencia, etc.), y puede repetirse. Las complicaciones pueden incluir formaci&#xf3;n de abscesos y migraci&#xf3;n de f&#xed;stulas a ubicaciones anat&#xf3;micas adyacentes (vagina). Incluso si no tiene &#xe9;xito, despu&#xe9;s del tratamiento la f&#xed;stula puede migrar anat&#xf3;micamente distal volvi&#xe9;ndose m&#xe1;s superficial y brindando as&#xed; la oportunidad de proceder con una fistulotom&#xed;a retrasada. (Traducci&#xf3;n-Yesenia Rojas-Khalil ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kelley</LastName><ForeName>Scott R</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0003-1390-0019</Identifier><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vierkant</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Nursing, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cummings</LastName><ForeName>Kayleigh M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Nursing, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berndt</LastName><ForeName>Shannon R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Nursing, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012003" MajorTopicYN="Y">Rectal Fistula</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054023" MajorTopicYN="Y">Lasers, Semiconductor</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053685" MajorTopicYN="Y">Laser Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014945" MajorTopicYN="N">Wound Healing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cryptoglandular</Keyword><Keyword MajorTopicYN="N">Fistula-in-ano</Keyword><Keyword MajorTopicYN="N">Laser</Keyword><Keyword MajorTopicYN="N">Radially emitting diode</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>6</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>6</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39239958</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003501</ArticleId><ArticleId IdType="pii">00003453-990000000-00736</ArticleId></ArticleIdList><ReferenceList><Title/><Reference><Citation>Zanotti C, Martinez-Puente C, Pascual I, Pascual M, Herreros D, Garcia-Olmo D. An assessment of the incidence of fistula in ano in four countries of the European Union. Int J Colorectal Dis. 2007;22:1459&#x2013;1462.</Citation></Reference><Reference><Citation>Sanchez-Haro E, Vela E, Cleries M, et al. Clinical characterization of patients with anal fistula during follow-up of anorectal abscess: a large population-based study. Tech Coloproctol. 2023;27:897&#x2013;907.</Citation></Reference><Reference><Citation>Wilhelm A. A new technique for sphincter-preserving anal fistula repair using a novel radial emitting laser probe. Tech Coloproctol. 2011;15:445&#x2013;449.</Citation></Reference><Reference><Citation>D&#xf6;nmez T, Hatipo&#x11f;lu E. Closure of fistula tract with Filac TM laser as a sphincter preserving method in anal fistula treatment. Turk J Colorectal Dis. 2017;27:142&#x2013;147.</Citation></Reference><Reference><Citation>Wilhelm A, Fiebig A, Krawczak M. Five years of experience with the FiLaC TM laser for fistula-in-ano management: longterm follow-up from a single institution. Tech Coloproctol. 2017;21:269&#x2013;276.</Citation></Reference><Reference><Citation>Lauretta A, Falco N, Stocco E, Bellomo R, Infantino A. Anal fistula laser closure: the length of fistula is the achilles&#x2019; heel. Tech Coloproctol. 2018;22:933&#x2013;939.</Citation></Reference><Reference><Citation>Terzi MC, Agalar C, Habip S, Canda AE, Arslan NC, Obuz F. Closing perianal fistulas using a laser: long-term results in 103 patients. Dis Colon Rectum. 2018;61:599&#x2013;603.</Citation></Reference><Reference><Citation>De Hous N, de Gheldere C, Van den Broeck S, Komen N. FiLaC TM as a last, sphincter-preserving resort for complex perianal fistula. Tech Coloproctol. 2019;23:937&#x2013;938.</Citation></Reference><Reference><Citation>Marref I, Spindler L, Aubert M, et al. The optimal indication for FiLaC &#xae; is high trans-sphincteric fistula-in-ano: a prospective cohort of 69 consecutive patients. Tech Coloproctol. 2019;23:893&#x2013;897.</Citation></Reference><Reference><Citation>Stijns J, van Loon YT, Clermonts SHEM, G&#x4e7;ttgens KW, Wasowicz DK, Zimmerman DDE. Implementation of laser ablation of fistula tract (LAFT) for perianal fistulas: do the results warrant continued application of this technique? Tech Coloproctol. 2019;23:1127&#x2013;1132.</Citation></Reference><Reference><Citation>Alam A, Lin F, Fathallah N, et al. FiLaC &#xae; and Crohn&#x2019;s disease perianal fistulas: a pilot study of 20 consecutive patients. Tech Coloproctol. 2020;24:75&#x2013;78.</Citation></Reference><Reference><Citation>Brabender DE, Moran KL, Brady M, et al. Assessing the effectiveness of laser fistulectomy for anal fistula: a retrospective cohort study. Tech Coloproctol. 2020;24:1071&#x2013;1075.</Citation></Reference><Reference><Citation>de Bonnechose G, Lefevre JH, Aubert M, et al. Laser ablation of fistula tract (LAFT) and complex fistula-in-ano: &#x201c;the ideal indication&#x201d; is becoming clearer. Tech Coloproctol. 2020;24:695&#x2013;701.</Citation></Reference><Reference><Citation>Isik O, Gulcu B, Ozturk E. Long-term outcomes of laser ablation of fistula tract for fistula-in-ano: a considerable option in sphincter preservation. Dis Colon Rectum. 2020;63:831&#x2013;836.</Citation></Reference><Reference><Citation>Serin KR, Hacim NA, Karabay O, Terzi MC. Retrospective analysis of primary suturing of the internal orifice of perianal fistula during FiLaC procedure. Surg Laparosc Endosc Percutan Tech. 2020;30:266&#x2013;269.</Citation></Reference><Reference><Citation>Giamundo P, De Angelis M. Treatment of anal fistula with FiLaC( &#xae; ): results of a 10-year experience with 175 patients. Tech Coloproctol. 2021;25:941&#x2013;948.</Citation></Reference><Reference><Citation>Nordholm-Carstensen A, Perregaard H, Hagen KB, Krarup PM. Fistula laser closure (FiLaC TM ) for fistula-in-ano-yet another technique with 50% healing rates? Int J Colorectal Dis. 2021;36:1831&#x2013;1837.</Citation></Reference><Reference><Citation>Wolicki A, J&#xe4;ger P, Deska T, Senkal M. Sphincter-saving therapy for fistula-in-ano: long-term follow-up after FiLaC. Tech Coloproctol. 2021;25:177&#x2013;184.</Citation></Reference><Reference><Citation>Sluckin TC, Gispen WH, Jongenotter J, et al. Treatment of cryptoglandular fistulas with the fistula tract laser closure(FiLaC TM ) method in comparison with standard methods: first results of a multicenter retrospective comparative study in the Netherlands. Tech Coloproctol. 2022;26:797&#x2013;803.</Citation></Reference><Reference><Citation>Olajide TO, Bode CO. Closure of fistula-in-ano using a radial-emitting laser probe: initial experience in Lagos, Nigeria. J West Afr Coll Surg. 2023;13:101&#x2013;106.</Citation></Reference><Reference><Citation>Blanco Ter&#xe9;s L, Bermejo Marcos E, Cerd&#xe1;n Santacruz C, et al. FiLaC &#xae; procedure for highly selected anal fistula patients: indications, safety and efficacy from an observational study at a tertiary referral center. Rev Esp Enferm Dig. 2023;115:700&#x2013;706.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>